A turnaround biotech with Tau IP and an aggressive CEO with capital experience that just R/S? Sounds like share structure catching-up with prospects, to me.
I'll keep saying it...the science is real...the stock is a total SCAM...IMO.
If this continues the pattern it's following, I'll be 4-for-4 on AZ stocks this year. GLTA §ILNS In @ .28